← Back to patent-cliff list
Germinal Peptide
Tier C — Watch / tradeGerminal Peptide
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：TMSB4
Indications (approved)：角膜疾病, 角膜损伤, Fuchs endothelial corneal dystrophy, 角膜内皮细胞损失, Dry eye disease
Regional status
US
-
EU
-
China
Phase II
2020-12-24
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Germinal Peptide?
Approved indications include: 角膜疾病, 角膜损伤, Fuchs endothelial corneal dystrophy, 角膜内皮细胞损失, Dry eye disease.
When does the Germinal Peptide patent expire?
No public expiry year is available for Germinal Peptide yet; this page updates once verified.
How do I get a quote for Germinal Peptide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06